Cargando…
Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient
A 57-year-old man without underlying diseases presented with fatigue, loss of appetite, and jaundice 1 week after receiving the first dose of the BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccine and showed hemolytic anemia with fragmented erythrocytes and severe thrombocytopenia 2 weeks aft...
Autores principales: | Yoshida, Kikuaki, Sakaki, Ayaka, Matsuyama, Yoriko, Mushino, Toshiki, Matsumoto, Masanori, Sonoki, Takashi, Tamura, Shinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866790/ https://www.ncbi.nlm.nih.gov/pubmed/34803105 http://dx.doi.org/10.2169/internalmedicine.8568-21 |
Ejemplares similares
-
Sudden Cardiac Death in a Patient with Thrombotic Thrombocytopenic Purpura: A Case Report
por: Yoshida, Kikuaki, et al.
Publicado: (2022) -
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
por: Güney, Tekin, et al.
Publicado: (2022) -
Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
por: Fenoglio, Roberta, et al.
Publicado: (2022) -
Progressive Massive Splenomegaly in an Adult Patient with Kabuki Syndrome Complicated with Immune Thrombocytopenic Purpura
por: Mushino, Toshiki, et al.
Publicado: (2021) -
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021)